Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email



SEP 17, 2013 - Yahoo! News

A Must Read - Share

UK cost agency questions benefits of Sanofi MS pill

LONDON (Reuters) - Britain's healthcare cost watchdog wants more information from Sanofi on the effectiveness of its new multiple sclerosis pill Aubagio before deciding if it should be used on the state health service. The National Institute for Health and Clinical Excellence (NICE), which decides if drugs should be paid for by the system, said on Wednesday it had asked the French drugmaker's Genzyme unit to come up with additional information by October 8. Sanofi has already offered to provide Aubagio at a discount to the National Health Service. ...

Tags: UK cost agency questions benefits of Sanofi MS pill,  Multiple Sclerosis Latest News